CARsgen Therapeutics Holdings Limited (HKG:2171)
Hong Kong · Delayed Price · Currency is HKD 12.85
-0.65 (-4.81%)
Jul 30, 2026, 4:08 PM HKT
HKG:2171 Market Cap
HKG:2171 has a market cap or net worth of 8.03 billion as of July 30, 2026. Its market cap has decreased by -37.63% in one year.
Market Cap
8.03B
Enterprise Value
6.84B
Revenue
139.84M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.85
ChartMarket Cap Chart
Since June 18, 2021, HKG:2171's market cap has decreased from 17.02B to 8.03B, a decrease of -52.83%. That is a compound annual growth rate of -13.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 8.03B | -2.73% |
| Dec 31, 2025 | 8.25B | 63.11% |
| Dec 31, 2024 | 5.06B | 35.24% |
| Dec 29, 2023 | 3.74B | -56.36% |
| Dec 30, 2022 | 8.57B | -45.06% |
| Dec 31, 2021 | 15.61B | -8.30% |
| Jun 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ascletis Pharma | 9.49B |
| Shaanxi Micot Pharmaceutical Technology | 9.34B |
| TenNor Therapeutics (Suzhou) | 8.78B |
| Everest Medicines | 8.72B |
| Suzhou Ribo Life Science | 8.51B |
| Lepu Biopharma | 8.28B |
| Alphamab Oncology | 7.69B |
| Abbisko Cayman | 7.42B |